Document is current
Any future updates will be listed below
-
Authors
Hanna, Amira L.
Elgebaly, Atef S.
Mohmed, Magdy M.
Sadik, Mahmoud W.
Hamouda, Hayam M.
Goda, Hanan A.
Altrawy, Afaf
-
Funding
Funding for this research was provided by:
Misr University for Science & Technology
- License Information
-
More Information
Article History
Received: 28 November 2025
Accepted: 3 February 2026
First Online: 26 February 2026
Declarations
:
: All experimental procedures were conducted in accordance with the ethical standards set by the national health and medical research council and the Egyptian ministry of health and population. The study protocol was approved by the research ethical committee of the national organization for drug control and research (NODCAR), Egyptian drug authority (EDA), Egypt, under ethics approval number: NODCAR/1/1/2023. Animal experiments were performed in accordance with the ARRIVE guidelines 2.0 to ensure rigorous and transparent reporting of in vivo studies. All efforts were made to minimize animal suffering and to use the minimum number of animals necessary to achieve scientific objectives.
: The authors declare no competing interests.
